Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

Agenus Inc. (AGEN)

-NasdaqCM
5.57 Down 0.05(0.89%) Apr 17, 4:00PM EDT
|After Hours : 5.57 Down 0.00 (0.01%) Apr 17, 4:22PM EDT
Add to Portfolio
Prev Close:5.62
Open:5.58
Bid:5.11 x 300
Ask:5.77 x 73500
1y Target Est:9.25
Beta:0.23
Earnings Date:May 6 - May 11 (Est.)
Day's Range:5.45 - 5.63
52wk Range:2.46 - 6.49
Volume:669,961
Avg Vol (3m):1,054,580
Market Cap:394.13M
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 0.89%394.13M
ABPI 0.00%N/A
DNDN 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):56.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.38
Quarterly EPS Est (Mar-15) :-0.01
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback